Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Infertility in Males01:23

Infertility in Males

Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Spermatogenesis01:41

Spermatogenesis

Spermatogenesis is the process by which haploid sperm cells are produced in the male testes. It starts with stem cells located close to the outer rim of seminiferous tubules. These spermatogonial stem cells divide asymmetrically to give rise to additional stem cells (meaning that these structures “self-renew”), as well as sperm progenitors, called spermatocytes. Importantly, this method of asymmetric mitotic division maintains a population of spermatogonial stem cells in the male reproductive...
Infertility in Females01:28

Infertility in Females

Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of endometrial...
Accessory Ducts of the Male Reproductive System01:25

Accessory Ducts of the Male Reproductive System

The male reproductive system is a complex network of organs and tissues that work together to produce and transport sperm. The epididymis, vasa deferens, ejaculatory ducts, and urethra are the accessory ducts involved in sperm maturation and transportation. These ducts play a critical role in the production and transportation of sperm from the testes to the urethra, where it is then released during ejaculation.
The epididymis is a small, comma-shaped organ located at the back of each testicle.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inframalleolar Status According to the Global Limb Anatomic Staging System Is Associated With Wound Recurrence After Complete Wound Healing in Patients With Chronic Limb-Threatening Ischemia.

Journal of vascular surgery·2026
Same author

Recipient-derived macrophages mediate acute cardiac allograft rejection via GSDMD-induced pyroptosis mechanism.

Clinical and translational medicine·2026
Same author

Automated radiographic shoulder balance assessment in scoliosis <i>via</i> deep learning.

Global health & medicine·2026
Same author

Prevalence and complementary distribution of FGFR3 alterations and ERBB2 amplification in metastatic urothelial carcinoma: a nationwide registry analysis.

International journal of clinical oncology·2026
Same author

Three-Year Outcomes of Supera Interwoven Nitinol Stents Versus Eluvia Drug-Eluting Stents in Severely Calcified Femoropopliteal Lesions.

Journal of vascular surgery·2026
Same author

Molecular mechanisms of naturally encoded signaling bias at the complement anaphylatoxin receptors.

Molecular cell·2026

Related Experiment Video

Updated: Jun 5, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

Finasteride-associated male infertility.

Koji Chiba1, Kohei Yamaguchi, Fuping Li

  • 1Division of Urology, Department of Surgery Related, Kobe University Graduate School of Medicine, Kobe, Japan.

Fertility and Sterility
|January 4, 2011
PubMed
Summary

Finasteride (1-mg dose) use was associated with male infertility in a patient with pre-existing low sperm count. Discontinuing finasteride improved semen parameters, enabling less invasive fertility treatments.

More Related Videos

Mouse Round Spermatid Injection
08:41

Mouse Round Spermatid Injection

Published on: January 26, 2024

Related Experiment Videos

Last Updated: Jun 5, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

Mouse Round Spermatid Injection
08:41

Mouse Round Spermatid Injection

Published on: January 26, 2024

Area of Science:

  • Endocrinology
  • Reproductive Medicine
  • Pharmacology

Background:

  • Finasteride is a 5α-reductase inhibitor commonly prescribed for androgenic alopecia.
  • Male infertility affects a significant portion of the population, with multifactorial causes.
  • Semen parameters are crucial indicators of male reproductive health.

Observation:

  • A male patient with a history of oligospermia developed azoospermia while using 1-mg finasteride for androgenic alopecia.
  • The patient had been diagnosed with oligospermia five years prior to the current presentation.
  • Semen analysis revealed azoospermia during finasteride treatment.

Findings:

  • Discontinuation of finasteride led to immediate improvement in semen volume.
  • Sperm concentration increased to over 10 × 10^6/mL within 16 weeks of finasteride cessation.
  • The patient's improved semen parameters allowed for consideration of intrauterine insemination.

Implications:

  • Finasteride cessation can reverse drug-induced infertility and improve spermatogenesis.
  • Clinicians should consider finasteride's potential impact on male fertility, especially in patients with pre-existing semen abnormalities.
  • Evaluating and potentially discontinuing finasteride may be a viable strategy for infertile men on this medication.